Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and tolerability of tirbanibulin ointment 1% for actinic keratosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• tirbanibulin ointment 1% (tirbanibulin)

Snippet

Sponsor: Almirall, S.A. | Conditions: Keratosis, Actinic | Phase 3 | Status: COMPLETED | Results posted: 2024-01-23